As per Mr Jazir above ,
Yes, the only difference seems to be a more concentrated portfolio and higher fees:
HML 2% p.a, 23% performance fee
BHD 3% p.a, 27% performance fee
Maybe it's worth it for 'high conviction'? But worth nothing that the BHD prospectus, while talking mostly about futures contracts, also remains open to unlisted investments.
- Forums
- ASX - By Stock
- HML
- Ann: Net Tangible Asset Backing
Ann: Net Tangible Asset Backing, page-53
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HML (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online